Physician profile
David Shin
NPI 1245372200
$1,016.15
in general payments reported to CMS, 2019-2025
11 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Low Vision Rehabilitation provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $36.64 · 2022: $58.17 · 2023: $75.01 · 2024: $307 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Entertainment: $64.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.50 |
| Entertainment | $64.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $195.89 | 2022-2025 | Dailies, Precision7, Argos |
| Johnson & Johnson Vision Care, INC. | $187.62 | 2019-2025 | Acuvue |
| Lkc Technologies, INC. | $135.70 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $129.05 | 2019 | |
| Coopervision INC. | $128.56 | 2019-2024 | Clariti Contact Lens |
| Maculogix, INC. | $82.00 | 2019 | |
| Optos, INC. | $64.06 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visionix USA, INC | $38.46 | 2024 | Optical Coherence Tomography Hoct-1f |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $18.17 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.